metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) PIK3CA-related overgrowth spectrum (PROS): New insight in known diseases
Journal Information

Statistics

Follow this link to access the full text of the article

Review
PIK3CA-related overgrowth spectrum (PROS): New insight in known diseases
Síndromes de sobrecrecimiento relacionados con PIK3CA (PROS): Conocimiento nuevo de enfermedades conocidas
Adriana Iriarte Fustera, Pau Cerdà Serraa, Antoni Riera-Mestrea,b,
Corresponding author
ariera@bellvitgehospital.cat

Corresponding author.
a Unidad de HHT y otras Enfermedades Minoritarias Vasculares, Servicio de Medicina Interna, Hospital Universitari de Bellvitge, Barcelona, Spain
b Facultad de Medicina y Ciencias de la Salud, Universitat de Barcelona, Barcelona, Spain
Read
3
Times
was read the article
2
Total PDF
1
Total HTML
Share statistics
 array:24 [
  "pii" => "S2387020621005702"
  "issn" => "23870206"
  "doi" => "10.1016/j.medcle.2021.03.018"
  "estado" => "S300"
  "fechaPublicacion" => "2021-11-26"
  "aid" => "5710"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "rev"
  "cita" => "Med Clin. 2021;157:483-8"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0025775321003006"
      "issn" => "00257753"
      "doi" => "10.1016/j.medcli.2021.03.036"
      "estado" => "S300"
      "fechaPublicacion" => "2021-11-26"
      "aid" => "5710"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "rev"
      "cita" => "Med Clin. 2021;157:483-8"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
        "titulo" => "S&#237;ndromes de sobrecrecimiento relacionados con <span class="elsevierStyleItalic">PIK3CA</span> &#40;PROS&#41;&#58; Conocimiento nuevo de enfermedades conocidas"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "483"
            "paginaFinal" => "488"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "<span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum &#40;PROS&#41;&#58; new insight in known diseases"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 348
                "Ancho" => 2508
                "Tamanyo" => 54171
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Imagen esquem&#225;tica de la prote&#237;na PI3K con los dominios identificados&#46; Los n&#250;meros debajo de cada dominio corresponden a los amino&#225;cidos de inicio y final para dichos dominios&#46; Las estrellas corresponden a la ubicaci&#243;n de los tres <span class="elsevierStyleItalic">hotspots</span> indicados en el texto&#46; Los dominios de la prote&#237;na son&#58; i&#41; ABD&#58; <span class="elsevierStyleItalic">adaptor-binding domain</span>&#44; se encarga de interaccionar con la prote&#237;na p85&#44; reguladora de la v&#237;a&#59; ii&#41; RBD&#58; <span class="elsevierStyleItalic">ras-binding domain</span>&#44; lugar de interacci&#243;n entre PI3K y la cascada de se&#241;alizaci&#243;n RAS&#59; iii&#41; C2&#58; dominio con estructura de s&#225;ndwich &#946; de funci&#243;n desconocida&#59; iv&#41; helicoidal&#58; es un dominio con conformaci&#243;n tridimensional helicoidal de funci&#243;n desconocida&#59; v&#41; cinasa &#40;quinasa&#41;&#58; dominio catal&#237;tico responsable de fosforilar los efectores de la v&#237;a&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Adriana Iriarte Fuster, Pau Cerd&#224; Serra, Antoni Riera-Mestre"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Adriana"
                "apellidos" => "Iriarte Fuster"
              ]
              1 => array:2 [
                "nombre" => "Pau"
                "apellidos" => "Cerd&#224; Serra"
              ]
              2 => array:2 [
                "nombre" => "Antoni"
                "apellidos" => "Riera-Mestre"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2387020621005702"
          "doi" => "10.1016/j.medcle.2021.03.018"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621005702?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321003006?idApp=UINPBA00004N"
      "url" => "/00257753/0000015700000010/v1_202111140539/S0025775321003006/v1_202111140539/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2387020621005726"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2021.03.019"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-26"
    "aid" => "5680"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Med Clin. 2021;157:489-94"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
      "titulo" => "Contributions from a multidisciplinary committee for the prevention of infections in patients with targeted immunosuppressive therapy"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "489"
          "paginaFinal" => "494"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Aportaciones de un comit&#233; multidisciplinar para la prevenci&#243;n de infecciones en pacientes tratados con inmunosupresores selectivos"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1660
              "Ancho" => 2917
              "Tamanyo" => 667141
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Infection exposure according to geographical origin&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lourdes Mateo, M&#46; Luisa Pedro-Botet, Mar&#237;a Guadalupe Esteve, Jos&#233; Manuel Carrascosa"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Lourdes"
              "apellidos" => "Mateo"
            ]
            1 => array:2 [
              "nombre" => "M&#46; Luisa"
              "apellidos" => "Pedro-Botet"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a Guadalupe"
              "apellidos" => "Esteve"
            ]
            3 => array:2 [
              "nombre" => "Jos&#233; Manuel"
              "apellidos" => "Carrascosa"
            ]
            4 => array:1 [
              "colaborador" => "on behalf of the Committee of infections in patients treated with selective immunosuppressants of the Hospital Germans Trias i Pujol"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S002577532100244X"
        "doi" => "10.1016/j.medcli.2021.03.031"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532100244X?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621005726?idApp=UINPBA00004N"
    "url" => "/23870206/0000015700000010/v2_202201010925/S2387020621005726/v2_202201010925/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S238702062100591X"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2021.09.005"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-26"
    "aid" => "5787"
    "copyright" => "The Author&#40;s&#41;"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Med Clin. 2021;157:480-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial article</span>"
      "titulo" => "The time for high value practices"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "480"
          "paginaFinal" => "482"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "La oportunidad de promover las pr&#225;cticas de alto valor"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jose Joaquin Mira Solves"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jose Joaquin"
              "apellidos" => "Mira Solves"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775321005066"
        "doi" => "10.1016/j.medcli.2021.09.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321005066?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S238702062100591X?idApp=UINPBA00004N"
    "url" => "/23870206/0000015700000010/v2_202201010925/S238702062100591X/v2_202201010925/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
    "titulo" => "<span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum &#40;PROS&#41;&#58; New insight in known diseases"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "483"
        "paginaFinal" => "488"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Adriana Iriarte Fuster, Pau Cerd&#224; Serra, Antoni Riera-Mestre"
        "autores" => array:3 [
          0 => array:3 [
            "nombre" => "Adriana"
            "apellidos" => "Iriarte Fuster"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Pau"
            "apellidos" => "Cerd&#224; Serra"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Antoni"
            "apellidos" => "Riera-Mestre"
            "email" => array:1 [
              0 => "ariera@bellvitgehospital.cat"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Unidad de HHT y otras Enfermedades Minoritarias Vasculares&#44; Servicio de Medicina Interna&#44; Hospital Universitari de Bellvitge&#44; Barcelona&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Facultad de Medicina y Ciencias de la Salud&#44; Universitat de Barcelona&#44; Barcelona&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "S&#237;ndromes de sobrecrecimiento relacionados con <span class="elsevierStyleItalic">PIK3CA</span> &#40;PROS&#41;&#58; Conocimiento nuevo de enfermedades conocidas"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1730
            "Ancho" => 2175
            "Tamanyo" => 178054
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Diagram of the canonical pathway of PI3K signaling activation and its intracellular signal transduction&#46; The solid arrows indicate the pathway&#44; and the dashed arrows point to negative feedback mechanisms&#46; The stars mark known therapeutic targets for which drugs are available&#44; which are outlined in cursive&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Phosphatidylinositol-4&#44;5-bisphosphate 3-kinase &#40;PI3K&#41;-related overgrowth syndromes&#44; known as the <span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum &#40;PROS&#41;&#44; are a heterogeneous group of rare diseases in which the presence of vascular malformations &#40;VMs&#41; is associated with segmental overgrowth of certain parts of the body&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The main characteristic shared by these diseases is that they are all caused by mutations in the gene encoding the alpha subunit of PI3K&#46;<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#44;3</span></a> It was when the genetic mechanisms underlying these diseases were discovered&#44; in 2014&#44; that the term PROS was first coined&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">This new spectrum of diseases was included in the latest update of the VMs classification of the International Society for the Study of Vascular Anomalies &#40;ISSVA&#41; in May 2018&#46;<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a> At present&#44; several diseases are included under the PROS concept&#44; all of them with specific phenotypic features&#44; but also with common characteristics that result in overlapping phenomena &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Their global epidemiological characteristics are poorly known&#44; although it is estimated that these entities separately have prevalence rates of less than 1&#47;1&#44;000&#44;000&#44; with a male&#47;female ratio of 1&#47;1&#46;3&#46;<span class="elsevierStyleSup">1&#44;2&#46;</span> This low prevalence means that&#44; despite encompassing several diseases&#44; the PROS is considered a rare disease &#40;ORPHA code 530313&#41;&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">The low prevalence and great clinical variability of these syndromes entail a highly complex diagnosis&#44; particularly in infrequent situations&#46; This is a common issue in the field of rare diseases&#44; in which case it is difficult to accumulate sufficient experience on the characteristics and natural course of a disease from a single site&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> The creation of registries could contribute to overcoming these difficulties and&#44; therefore&#44; represent a priority in the management of rare disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8&#44;9</span></a> The aim of this paper is to review the new view on PROS syndromes in order to contribute to the dissemination of these entities and&#44; thus&#44; to reach an optimal diagnosis of patients suffering them&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Pathophysiology</span><p id="par0020" class="elsevierStylePara elsevierViewall">Phosphatidylinositol-4&#44;5-bisphosphate 3-kinases &#40;PI3Ks&#41; form a family of enzymes known for their role in the signal transduction that stimulates cell growth&#44; proliferation&#44; and migration&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> This family is comprised by eight isoforms that are divided into three classes &#40;class I&#58; &#945;&#44; &#946;&#44; &#947;&#44; and &#948;&#59; class II&#58; &#945;&#44; &#946;&#44; and &#947;&#59; and class III&#41;&#44; each expressing in different cell types and with different functions&#44; some of which remain unknown to date&#46; Because of its role in the pathophysiology of certain solid tumors&#44; the best known and most studied isoform is class I subtype &#945; &#40;known as PIK3CA or p110&#945;&#41;&#44; which is encoded by the <span class="elsevierStyleItalic">PIK3CA</span> gene&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> This PIK3CA isoform is involved in the PROS and consists of five domains&#46; Most of its mutations &#40;over 80&#37;&#41; affect three specific codons &#40;called hotspots&#41;&#44; which encode two glutamic acids located at positions 542 and 545&#44; corresponding to the helical domain&#44; and a histidine located at position 1&#44;047&#44; corresponding to the catalytic domain of the kinase &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Under normal conditions&#44; stimulation of tyrosine kinase receptors &#40;among others&#41; in the cell membrane activates the phosphorylation of PI3K&#44; which&#44; in turn&#44; catalyzes the conversion of phosphatidylinositol &#40;3&#44;4&#41;-bisphosphate &#40;PIP2&#41; to phosphatidylinositol &#40;3&#44;4&#44;5&#41;-triphosphate &#40;PIP3&#41;&#46; This phospholipid acts as a second messenger by recruiting cytoplasmic proteins that amplify the signal until it reaches its effectors&#46; Protein phosphatidylinositol-3&#44;4&#44;5-trisphosphate 3-phosphatase &#40;PTEN&#41; is a phosphatase that antagonizes the PI3K&#47;AKT&#47;mTOR &#40;where AKT is a serine&#47;threonine kinase also called protein kinase B&#44; and mTOR is the mammalian target of rapamycin&#41; signaling pathway by dephosphorylating PIP3 and thereby modulating the cell cycle progression&#46; Mutations in PI3K facilitate sequestering the enzyme in the cell membrane&#44; thus resulting in the constant production of PIP3 and&#44; in turn&#44; the permanent activation of the PI3K&#47;AKT&#47;mTOR signaling pathway&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;10</span></a> Although the molecular mechanics leading to the PROS phenotype are not yet well defined&#44; they are well known in the fields of oncology or isolated vascular malformations and&#44; therefore&#44; assumed to be similar or even equivalent &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">The mutations described are gain-of-function mutations in both cancer and the PROS&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;10</span></a> In fact&#44; PI3K hyperactivation causes vascular overgrowth in conditions other than the PROS&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> For example&#44; immunohistochemistry studies showed an <span class="elsevierStyleItalic">in situ</span> hyperactivation of PI3K in the telangiectases of patients with hereditary hemorrhagic telangiectasia &#40;HHT&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;12</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">However&#44; although mutations in the <span class="elsevierStyleItalic">PIK3CA</span> gene have also been linked to cancer in adult patients&#44; those with PROS syndromes exhibit approximately the same incidence of cancer as the general population&#44; which is explained by the pathophysiological characteristics of the PROS&#46; Moreover&#44; it must be noted that in the PROS&#44; although the <span class="elsevierStyleItalic">PIK3CA</span> mutations are somatic&#44; as in the case of cancer&#8212;that is&#44; not germline mutations and&#44; therefore&#44; not inherited&#8212;&#44; they occur during embryogenesis&#46; Thus&#44; the amount of tissue affected and&#44; as a result&#44; the extent of the lesions depends on the time of embryogenesis at which they occur &#40;earlier or later&#41;&#46; Another relevant pathophysiological aspect that also contributes to determining the phenotype is the specific primary germ layer &#40;ectoderm&#44; mesoderm&#44; or endoderm&#41; in which the mutation occurs&#44; as different tissues derive from each one of them&#46; These two aspects are crucial&#44; as the phenotype varies greatly depending on the time of embryonic development at which the mutations occur and the primary germ layer that they affect&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> This is why PROS syndromes can manifest from an isolated macrodactyly to more complex syndromes such as the CLOVES syndrome&#44; which combines overgrowth with VMs&#44; skin lesions&#44; and scoliosis &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Symptomatology</span><p id="par0040" class="elsevierStylePara elsevierViewall">Patients with PROS syndromes are characterized by presenting with segmental overgrowth of multiple tissues&#44; with vascular &#40;capillaries&#44; veins&#44; and lymphatic vessels&#41; and adipose tissues being the most involved at a macroscopic level&#46; Other characteristic findings are the presence of polydactyly&#44; cutaneous syndactyly&#44; renal and urinary tract anomalies &#40;agenesis&#44; hydronephrosis&#44; ureteral duplication&#44; or renal cysts&#41;&#44; and the presence of ovarian cysts and testicular hydroceles&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> As shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#44; the spectrum of PROS syndromes can be divided into either complex syndromic phenotypes with a high degree of involvement or isolated forms&#46; Although there was initially controversy surrounding the Klippel-Trenaunay syndrome&#44; the detection of <span class="elsevierStyleItalic">PIK3CA</span> mutations in these patients has now been confirmed&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Symptoms associated with the PROS depend on the extent of the overgrowth and the anatomical site affected by it&#44; with the lower limbs predominantly being affected&#44; mostly unilaterally and following a distal to proximal pattern&#46; Segmental overgrowth is often congenital&#44; although it can manifest during the first year of life and subsequently progress into adulthood in some cases&#46; The tissues that are mostly affected by this condition are the fibroadipose&#44; vascular&#44; nervous system&#44; and musculoskeletal ones&#46; Vascular malformations may be present in 43&#37; of patients&#44; including capillary&#44; venous&#44; arteriovenous&#44; or lymphatic malformations&#44; and different types might even present concomitantly in some patients&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Patients with PROS syndromes have a higher risk of developing thromboembolic complications due to blood stasis caused by the VM itself&#44; the existence of localized intravascular coagulation characterized by high <span class="elsevierStyleSmallCaps">d</span>-dimer levels associated with fibrinogen and platelet consumption&#44; and the limited mobility of the patients themselves as a result of their pain and the asymmetric overgrowth of their limbs&#46;<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">16&#44;17</span></a> In fact&#44; elevation of D-dimer levels is characteristic of low-flow VMs&#44; as opposed to high-flow or arteriovenous VMs&#44; and translates into spontaneous thrombosis and thrombolysis phenomena secondary to venous stasis&#44; which activates the coagulation cascade&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> This prothrombotic condition can be further aggravated after a surgical procedure&#46; In this regard&#44; a particular study analyzed thromboembolic events in patients with PROS syndromes and reported that 64&#37; of pulmonary embolisms occurred following a surgical procedure or sclerotherapy&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Although <span class="elsevierStyleItalic">PIK3CA</span> mutations are very common in different types of tumors&#44; an increased incidence of cancer among patients with this condition has not been documented&#46; To date&#44; the only malignant tumor reported in patients with the PROS has been Wilms&#39; tumor &#40;nephroblastoma&#41;&#46; Although there is still not enough evidence to demonstrate that these patients are at an increased risk of developing these tumors&#44; it is advised that serial abdominal ultrasound scans be performed every three to four months until the age of eight years for their early detection&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Diagnosis</span><p id="par0060" class="elsevierStylePara elsevierViewall">Due to the phenotypic variability of the syndromes included in the PROS&#44; different diagnostic criteria have been proposed to help clinicians evaluate patients suffering from them&#46; As they are congenital or early childhood onset disorders&#44; they are characterized by an absence of a family history &#40;sporadic cases&#41; and a mosaic distribution&#46; Overall&#44; most patients present with a progressive disease and might manifest the full spectrum of clinical manifestations of the disease or only isolated ones&#46; The diagnostic criteria are subdivided into mandatory common features and two main categories&#46; To reach the diagnosis&#44; the common characteristics must be present in association with at least two criteria from group A &#40;syndromic forms&#41; or one from group B &#40;isolated forms&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">Multiple phenotypes associated with mutations in the PI3K&#47;AKT&#47;mTOR pathway and leading to a spectrum of segmental overgrowth syndromes have been described&#46; Therefore&#44; other diseases should also be considered in the differential diagnosis of the PROS&#44; such as the Proteus syndrome&#44; which is characterized by an asymmetric overgrowth of the lower limbs and the growth of cerebriform nevi&#59; PTEN hamartoma tumor syndrome&#44; which is characterized by the existence of macrocephaly&#44; skin lesions such as trichilemmomas&#44; and the growth of lipomas and hamartomas in the gastrointestinal tract&#44; the skin&#44; and the thyroid gland&#59; as well as tuberous sclerosis complex &#40;TSC1&#47;2&#41;&#44; which presents with central nervous system involvement associated with characteristic skin lesions&#44; such as facial angiofibromas and the growth of tumors in multiple organs &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#41;&#46; The Parkes-Weber syndrome&#44; like other syndromes caused by mutations in the <span class="elsevierStyleItalic">RASA1</span> gene&#44; is characterized by high-flow &#40;arteriovenous&#41; fistulas&#46; Their main complication is heart failure associated with a high cardiac output and&#44; although they also cause overgrowth of the affected limb&#44; they should not be confused with a PROS syndrome&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> However&#44; we now know that these other overgrowth syndromes manifest with other clinical characteristics that do not meet the criteria set for PROS syndromes and&#44; above all&#44; that they are due to other genetic causes&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">Therefore&#44; the identification of specific mutations in affected individuals is important because of the potential diagnostic and therapeutic implications they represent&#46; However&#44; reaching a genetic diagnosis for PROS syndromes is not straightforward and is challenging in several ways&#46; This is because <span class="elsevierStyleItalic">PIK3CA</span> mutations occur as a postzygotic event&#44; causing somatic mosaicism&#44; owing to which pathogenic variants are usually undetectable in the blood or tissues of normal appearance&#44; and consequently only detected in the affected organs&#46; Because of this&#44; the genetic diagnosis of a PROS syndrome involves the conduct of a biopsy&#44; which is often complex because the lesions are hypervascularized&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> In addition&#44; which tissue is most likely to have the mutation should be determined&#46; It should be noted that some biopsies from these patients may exhibit a very low level of mosaicism &#40;&#60;5&#37;&#41;&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Hence&#44; either a molecular diagnosis with high-throughput sequencing techniques&#44; such as next generation sequencing &#40;NGS&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> or the use of other more specific techniques&#44; such as a Droplet Digital polymerase chain reaction &#40;ddPCR&#41; and customized restriction fragment length polymorphism &#40;RFLP&#41; assays&#44; is required&#46; The latter methods identify specific <span class="elsevierStyleItalic">PIK3CA</span> mutations and are able to detect very low percentages of mosaicism in the cells under study &#40;0&#46;5&#37;&#8211;0&#46;001&#37;&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">Because of these difficulties&#44; one must bear in mind that a negative result does not rule out the diagnosis of a PROS syndrome in patients with compatible phenotypes&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Treatment</span><p id="par0085" class="elsevierStylePara elsevierViewall">The therapeutic approach for overgrowth syndromes has classically consisted in conservative management&#44; limited to treating complications arising from the overgrowth through the use of compressive therapies&#44; surgical excision&#44; orthopedic surgery&#44; sclerotherapy&#44; and&#47;or embolization&#46; These strategies are probably insufficient&#44; as the condition often progresses&#44; and these patients tend to experience a relapse during their follow-up&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">The identification of the PIK3&#47;AKT&#47;mTOR activation pathway has been a therapeutic breakthrough for these patients&#46; Because mTOR is a downstream effector of the PI3K signaling pathway&#44; the use of a specific inhibitor&#44; such as sirolimus&#44; has proven to be an attractive therapeutic strategy in patients with PROS syndromes&#46; Several studies performed to date have demonstrated its benefit in venous and lymphatic malformations in both pediatric and adult patients&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> A modest clinical and radiological improvement has been demonstrated particularly in PROS syndromes&#44; although these treatments are not free of adverse effects&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">In this regard&#44; different PIK3 inhibitors have been approved for the treatment of several oncohematological diseases in which gain-of-function mutations are observed in this gene&#46; A selective <span class="elsevierStyleItalic">PIK3CA</span> inhibitor&#44; called alpelisib&#44; has recently been approved in Spain for the treatment of locally advanced or metastatic breast cancer with a <span class="elsevierStyleItalic">PIK3CA</span> mutation&#46; One particular study analyzed the compassionate use of alpelisib in 19 patients with various phenotypic expressions of the PROS&#44; including six patients with CLOVES syndrome&#44; two with macrocephaly-capillary malformation &#40;MCAP&#41; syndrome&#44; and nine patients with localized overgrowth&#46; All patients exhibited remarkable improvements&#44; including a reduction in their capillary malformations and epidermal nevi&#44; cessation of their chronic gastrointestinal bleeding&#44; an improvement in their scoliosis&#44; and an improvement in the cognitive function of the two patients with MCAP&#46; In this patient cohort&#44; alpelisib was well tolerated and caused few adverse effects&#46;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">Due to the complexity of these diseases and the wide range of complications that these patients can experience during their follow-up&#44; specialized multidisciplinary units involved in the diagnosis&#44; follow-up&#44; and optimal management of patients affected by PROS syndromes should be created&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusions</span><p id="par0105" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum syndromes are a group of very phenotypically diverse entities caused by mutations in the gene encoding PIK3CA and are globally considered a rare disease &#40;ORPHA code 530313&#41;&#46; Knowledge of the clinical characteristics of patients with PROS syndromes&#44; as well as the use of clinical and molecular diagnostic strategies&#44; is important for reaching an early diagnosis and preventing potential associated complications&#46; Further delving into these aspects will contribute to obtaining necessary tools to develop new therapeutic strategies for patients with PROS syndromes&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Funding sources</span><p id="par0110" class="elsevierStylePara elsevierViewall">This study was partially funded by the Carlos III Health Institute &#40;<span class="elsevierStyleItalic">Instituto de Salud Carlos III</span>&#41; through project PI17&#47;00669 &#40;co-financed by the European Regional Development Fund &#91;ERDF&#93;&#44; &#8220;A way of doing Europe&#8221;&#41;&#46; It was also partially funded by a 2019&#8211;2021 research grant from the Research Committee of <span class="elsevierStyleItalic">Hospital Universitari de Bellvitge</span> &#40;Barcelona&#44; Spain&#41;&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conflicts of interest</span><p id="par0115" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:13 [
        0 => array:3 [
          "identificador" => "xres1639957"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1462304"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1639956"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1462303"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Pathophysiology"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Symptomatology"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Diagnosis"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Treatment"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conclusions"
        ]
        10 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Funding sources"
        ]
        11 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of interest"
        ]
        12 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-12-24"
    "fechaAceptado" => "2021-03-23"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1462304"
          "palabras" => array:4 [
            0 => "<span class="elsevierStyleItalic">PIK3CA-</span>related overgrowth spectrum &#40;PROS&#41;"
            1 => "Phosphatidylinositol 4&#44;5-bisphosphate 3-kinase &#40;PI3K&#41;"
            2 => "Vascular malformation"
            3 => "Rare diseases"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1462303"
          "palabras" => array:4 [
            0 => "S&#237;ndromes de sobrecrecimiento relacionados con <span class="elsevierStyleItalic">PIK3CA</span> &#40;PROS&#41;"
            1 => "fosfatidilinositol-4&#44;5-bifosfato 3-cinasa &#40;PI3K&#41;"
            2 => "Malformaciones vasculares"
            3 => "Enfermedades minoritarias"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">The overgrowth syndromes related to phosphatidylinositol-4&#44;5-bisphosphate 3-kinase &#40;PI3K&#41; are grouped under the concept of PROS &#40;<span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum&#41;&#46; It is a heterogeneous group of diseases&#44; considered a rare disease &#40;ORPHA&#58; 530&#44;313&#41;&#44; which combines the presence of vascular malformations with segmental overgrowth of some parts of the body&#46; All these diseases are caused by mutations in the gene that encodes for the alpha subunit of PI3K&#46; These mutations are somatic and take place during the embryonic stage&#46; Depending on the stage of embryonic development and the affected germ layers&#44; the phenotype will be very different&#44; from syndromes with extensive involvement to isolated forms&#46; Although there are clinical criteria&#44; identification of the mutation by biopsy&#44; although complex&#44; confirms the diagnosis&#46; The objective of the present study is to review the pathophysiological&#44; clinical&#44; diagnostic&#44; and therapeutic aspects of PROS&#44; in order to optimize its identification&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Los s&#237;ndromes de sobrecrecimiento relacionados con la fosfatidilinositol-4&#44;5-bifosfato 3-cinasa &#40;PI3K&#41;&#44; se agrupan bajo el concepto de PROS &#40;<span class="elsevierStyleItalic">PIK3CA</span>-<span class="elsevierStyleItalic">related overgrowth spectrum</span>&#41;&#46; Son un grupo heterog&#233;neo de entidades&#44; considerado una enfermedad minoritaria &#40;ORPHA&#58; 530313&#41;&#44; que combina la presencia de malformaciones vasculares con el sobrecrecimiento segmentario de algunas partes del cuerpo&#46; Todas estas enfermedades est&#225;n causadas por mutaciones en el gen que codifica la subunidad alfa de la PI3K&#46; Estas mutaciones son som&#225;ticas y tienen lugar durante la embriog&#233;nesis&#46; Dependiendo del momento del desarrollo embrionario que se produzcan y a qu&#233; hoja precursora afecten&#44; el fenotipo ser&#225; muy distinto&#44; desde s&#237;ndromes con extensa afectaci&#243;n a formas aisladas&#46; Aunque existen unos criterios cl&#237;nicos&#44; la identificaci&#243;n de la mutaci&#243;n mediante realizaci&#243;n de una biopsia&#44; aunque compleja&#44; confirma el diagn&#243;stico&#46; El objetivo del presente trabajo es revisar los aspectos fisiopatol&#243;gicos&#44; cl&#237;nicos&#44; diagn&#243;sticos y terap&#233;uticos del PROS&#44; con el fin de optimizar su identificaci&#243;n&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Please cite this article as&#58; A&#46; Iriarte Fuster&#44; P&#46; Cerd&#224; Serra and A&#46; Riera-Mestre&#44; S&#237;ndromes de sobrecrecimiento relacionados con <span class="elsevierStyleItalic">PIK3CA</span> &#40;PROS&#41;&#58; Conocimiento nuevo de enfermedades conocidas&#46; Med Clin &#40;Barc&#41;&#46; 2021&#59;157&#58;483&#8211;488&#46;</p>"
      ]
    ]
    "multimedia" => array:6 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 348
            "Ancho" => 2508
            "Tamanyo" => 51230
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Schematic image of the PI3K protein with the identified domains&#46; The numbers below each domain correspond to the initial and final amino acids of said domains&#46; The stars correspond to the location of the three hotspots described in the text&#46; The domains of the protein are&#58; i&#41; the adaptor-binding domain &#40;ABD&#41;&#44; which is responsible for interacting with pathway regulatory protein p85&#59; ii&#41; the ras-binding domain &#40;RBD&#41;&#44; corresponding to the site of interaction between PI3K and the RAS signaling cascade&#59; iii&#41; C2&#44; a domain of unknown function with a &#946; sandwich structure&#59; iv&#41; the helical domain of unknown function with a three-dimensional helical conformation&#59; and v&#41; the kinase catalytic domain responsible for phosphorylating the pathway effectors&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1730
            "Ancho" => 2175
            "Tamanyo" => 178054
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Diagram of the canonical pathway of PI3K signaling activation and its intracellular signal transduction&#46; The solid arrows indicate the pathway&#44; and the dashed arrows point to negative feedback mechanisms&#46; The stars mark known therapeutic targets for which drugs are available&#44; which are outlined in cursive&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1253
            "Ancho" => 2274
            "Tamanyo" => 128067
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Diagram showing how somatic mutations occurring at different moments of embryonic development can result in varying phenotypes and topographic distributions in both fetuses and adults&#46; The sooner they occur&#44; the more tissues and more cells of each tissue are affected&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0020"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">PROS syndromes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Clinical manifestations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Syndromic forms</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>CLOVES syndrome &#40;<span class="elsevierStyleItalic">congenital lipomatous overgrowth&#44; vascular malformations&#44; epidermal nevi&#44; skeletal&#47;spinal anomalies and&#47;or scoliosis&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lipomatous overgrowths on the trunk and limbs&#44; low-flow vascular malformations&#44; epidermal nevi&#44; scoliosis and&#47;or spinal deformities&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Klippel-Trenaunay syndrome &#40;KTS&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Several combinations of capillary&#44; venous&#44; and lymphatic malformations associated with limb overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Macrocephaly-capillary malformation &#40;MCAP or M-CM&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Megalencephaly or hemimegalencephaly&#44; polymicrogyria&#44; cerebellar tonsil herniation&#44; ventriculomegaly&#44; vascular malformations &#40;facial midline&#41;&#44; segmental overgrowth&#44; syndactyly&#44; polydactyly&#44; and connective tissue disorders&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Fibroadipose overgrowth &#40;FAO&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Progressive segmental overgrowth of the subcutaneous&#44; muscular&#44; and visceral fibroadipose tissue&#44; together with skeletal overgrowth&#44; peripheral nerve enlargement&#44; cutaneous capillary malformations&#44; testicular or epididymal cysts&#44; and hydroceles&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hemihyperplasia-multiple lipomatosis &#40;HHML&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Congenital overgrowth and asymmetry&#44; vascular skin anomalies&#44; and recurrent subcutaneous lipomas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Facial infiltrating lipomatosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hemifacial overgrowth associated with soft-tissue infiltration&#44; bone hypertrophy&#44; macrodontia&#44; hemimacroglossia&#44; early dental development&#44; and mucosal neuromas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Isolated forms</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Macrodactyly&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Overgrowth of one or more fingers&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Hemimegalencephaly&#44; dysplastic megalencephaly&#44; focal cortical dysplasia &#40;FCD&#41; type IIa&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Malformations of the cerebral cortex that are normally associated with epileptic seizures&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Muscular hemihyperplasia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Localized and non-progressive muscle overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Isolated lymphatic malformations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Dilated or cystic lymphatic vessels at any location&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Skin pathologies&#44; such as epidermal nevi and seborrheic keratosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Benign epithelial lesions caused by an overgrowth of cells in the outermost layer of the skin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Benign lichenoid keratosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Benign&#44; isolated skin lesions in the form of a brown or reddish papule or plaque&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2794089.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Spectrum of syndromic or isolated overgrowths associated with the <span class="elsevierStyleItalic">PIK3CA</span> gene&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0025"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">To reach the diagnosis&#44; the common features must be present in association with at least two criteria from group A or one from group B&#46; Table adapted from Keppler et al&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">Common characteristics &#40;<span class="elsevierStyleItalic">required</span>&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Existence of a somatic PIK3CA mutation<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Congenital or early childhood onset overgrowth</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sporadic cases &#40;absence of a family history&#41; and mosaic distribution</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Characteristics described in group A or B</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">A&#46; Syndromic forms &#40;two or more affected individuals&#41;</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">B&#46; Isolated forms</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46; Adipose&#44; musculoskeletal&#44; and nervous system overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46; Isolated lymphatic malformations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46; Capillary&#44; venous&#44; arteriovenous&#44; and&#47;or lymphatic vascular malformations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46; Isolated macrodactyly or feet&#47;hand&#47;limb overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46; Epidermal nevi&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46; Truncal adipose overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46; Megalencephaly&#47;focal cortical dysplasia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46; Epidermal nevi&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46; Seborrheic keratosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&#46; Benign lichenoid keratosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2794090.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">If no mutation is identified&#44; it should be considered as a potential PROS syndrome&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Generally progressive&#46; It may manifest as scoliosis &#40;kyphosis&#41;&#44; limb overgrowth&#44; central nervous system anomalies &#40;hydrocephalus&#44; cerebellar tonsillar ectopia&#44; Chiari malformation&#44; megalencephaly&#44; or mega-corpus callosum&#41;&#44; regional lipomatosis associated with overgrowth&#44; infiltrative lipomatosis&#44; Wilms&#8217; tumor&#44; or ovarian cystadenoma&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Established clinical criteria for the diagnosis of patients with <span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum&#46;</p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0030"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">PIK3CA&#58; phosphatidylinositol-4&#44;5-bisphosphate 3-kinase class I subtype &#945;&#46; AKT&#58; a serine&#47;threonine kinase also called protein kinase B&#46; PKB&#58; protein kinase B&#46; PKBA&#58; protein kinase B alpha&#46; PKBB&#58; protein kinase B beta&#46; PKBG&#58; protein kinase B gamma&#46; PTEN&#58; phosphatidylinositol-3&#44;4&#44;5-trisphosphate 3-phosphatase&#46; mTOR&#58; mammalian target of rapamycin&#46; TSC&#58; tuberous sclerosis complex&#46;</p><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Table adapted from Keppler et al&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">PI3K&#47;AKT&#47;mTOR pathway component&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Overgrowth syndromes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Clinical manifestations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">PIK3CA</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">PIK3CA</span>-related overgrowth spectrum &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">AKT</span> &#40;PKB&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">AKT1 &#40;PKBA&#41;&#58; Proteus syndrome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Overgrowth&#44; usually affecting the lower limbs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">AKT2 &#40;PKBB&#41;&#58; lipodystrophy-hypoglycemia syndrome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Recurrent severe fasting hypoglycemia&#44; decreased level of consciousness&#44; seizures&#44; and asymmetric growth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">AKT3 &#40;PKBG&#41;&#58; megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 &#40;MPPH2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">In utero</span> onset&#59; megalencephaly&#44; polymicrogyria&#44; postaxial polydactyly&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">mTOR</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Focal cortical dysplasia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Malformation of the cerebral cortex characterized by dysmorphic neurons associated with refractory epilepsy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">PTEN</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PTEN hamartoma tumor syndrome &#40;Cowden syndrome&#44; Bannayan-Riley-Ruvalcaba syndrome&#44; and PTEN-related Proteus syndrome&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Benign and malignant neoplasms&#59; brain overgrowth and neurodevelopmental anomalies&#44; asymmetrical bones and soft-tissue overgrowth&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">TSC1&#47;2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Tuberous sclerosis complex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hypopigmented macules&#44; facial angiofibromas&#44; ash leaf spots&#44; nail fibromas&#44; cortical tubercles&#44; subependymal nodules&#44; and subependymal giant cell astrocytomas&#44; seizures&#44; and intellectual disability&#47;developmental delay&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2794091.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Differential diagnosis of PROS syndromes <span class="elsevierStyleItalic">versus</span> other somatic overgrowth disorders associated with the PI3K&#47;AKT&#47;mTOR pathway&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:23 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "PIK3CA-related overgrowth spectrum &#40;PROS&#41;&#58; diagnostic and testing eligibility criteria&#44; differential diagnosis&#44; and evaluation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;M&#46; Keppler-Noreuil"
                            1 => "J&#46;J&#46; Rios"
                            2 => "V&#46;E&#46;R&#46; Parker"
                            3 => "R&#46;K&#46; Semple"
                            4 => "M&#46;J&#46; Lindhurst"
                            5 => "J&#46;C&#46; Sapp"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.36836"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2015"
                        "volumen" => "167A"
                        "paginaInicial" => "287"
                        "paginaFinal" => "295"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25557259"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;M&#46; Keppler-Noreuil"
                            1 => "J&#46;C&#46; Sapp"
                            2 => "M&#46;J&#46; Lindhurst"
                            3 => "V&#46;E&#46; Parker"
                            4 => "C&#46; Blumhorst"
                            5 => "T&#46; Darling"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.36552"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2014"
                        "volumen" => "164A"
                        "paginaInicial" => "1713"
                        "paginaFinal" => "1733"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24782230"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "PIK3CA mutations in vascular malformations"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;D&#46; Castillo"
                            1 => "E&#46; Baselga"
                            2 => "M&#46; Graupera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MOH.0000000000000496"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Hematol"
                        "fecha" => "2019"
                        "volumen" => "26"
                        "paginaInicial" => "170"
                        "paginaFinal" => "178"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30855339"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "ISSVA Classification of Vascular Anomalies 2018&#46; International Society for the Study of Vascular Anomalies&#46; Available at &#34;<a target="_blank" href="http://issva.org/classification">issva&#46;org&#47;classification</a>&#34;&#46; &#91;Accessed 23 November 2020&#93;&#46;"
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vascular malformations syndromes&#58; an update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Martinez-Lopez"
                            1 => "L&#46; Salvador-Rodriguez"
                            2 => "T&#46; Montero-Vilchez"
                            3 => "A&#46; Molina-Leyva"
                            4 => "J&#46; Tercedor-Sanchez"
                            5 => "S&#46; Arias-Santiago"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MOP.0000000000000812"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Pediatr"
                        "fecha" => "2019"
                        "volumen" => "31"
                        "paginaInicial" => "747"
                        "paginaFinal" => "753"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31693582"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Molecular Genetics of the PI3K-AKT-mTOR pathway in genodermatoses&#58; diagnostic implications and treatment opportunities"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46; Vahidnezhad"
                            1 => "L&#46; Yousse&#64257;an"
                            2 => "J&#46; Uitto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/JID.2015.331"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "2016"
                        "volumen" => "136"
                        "paginaInicial" => "15"
                        "paginaFinal" => "23"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26763419"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "RiHHTa Investigators of the Rare Diseases Working Group from the Spanish Society of Internal Medicine&#46; Current HHT genetic overview in Spain and its phenotypic correlation&#58; data from RiHHTa registry"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; S&#225;nchez-Mart&#237;nez"
                            1 => "A&#46; Iriarte"
                            2 => "J&#46;M&#46; Mora-Luj&#225;n"
                            3 => "J&#46;L&#46; Patier"
                            4 => "D&#46; L&#243;pez-Wolf"
                            5 => "A&#46; Ojeda"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s13023-020-01422-8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Orphanet J Rare Dis"
                        "fecha" => "2020"
                        "volumen" => "15"
                        "paginaInicial" => "138"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32503579"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109719375953"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Creating an effective clinical registry for rare diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;M&#46; D&#8217;Agnolo"
                            1 => "W&#46; Kievit"
                            2 => "R&#46;J&#46; Andrade"
                            3 => "T&#46;H&#46; Karlsen"
                            4 => "H&#46; Wedemeyer"
                            5 => "J&#46;P&#46; Drenth"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "United Eur Gastroenterol J"
                        "fecha" => "2016"
                        "volumen" => "4"
                        "paginaInicial" => "333"
                        "paginaFinal" => "338"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "EURORDIS-NORD-CORD Joint Declaration of 10 Key Principles for Rare Disease Patient Registries&#44; Available from&#58; <a target="_blank" href="http://download.eurordis.org/documents/pdf/EURORDIS_NORD_CORD_JointDec_Registries_FINAL.pdf">http&#58;&#47;&#47;download&#46;eurordis&#46;org&#47;documents&#47;pdf&#47;EURORDIS&#95;NORD&#95;CORD&#95;JointDec&#95;Registries&#95;FINAL&#46;pdf</a>&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Revisiting PI3-kinase signalling in angiogenesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46; Kobialka"
                            1 => "M&#46; Graupera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1530/VB-19-0025"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vasc Biol"
                        "fecha" => "2019"
                        "volumen" => "1"
                        "paginaInicial" => "H125"
                        "paginaFinal" => "H134"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32923964"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Alsina-Sanchis"
                            1 => "Y&#46; Garc&#237;a-Ib&#225;&#241;ez"
                            2 => "A&#46;M&#46; Figueiredo"
                            3 => "C&#46; Riera-Domingo"
                            4 => "A&#46; Figueras"
                            5 => "X&#46; Matias-Guiu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/ATVBAHA.118.310760"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arterioscler Thromb Vasc Biol"
                        "fecha" => "2018"
                        "volumen" => "38"
                        "paginaInicial" => "1216"
                        "paginaFinal" => "1229"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29449337"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "PI3K &#40;phosphatidylinositol 3-kinase&#41; activation and endothelial cell proliferation in patients with hemorrhagic hereditary telangiectasia Type 1"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Iriarte"
                            1 => "A&#46; Figueras"
                            2 => "P&#46; Cerd&#224;"
                            3 => "J&#46;M&#46; Mora"
                            4 => "A&#46; Jucgl&#224;"
                            5 => "R&#46; Pen&#237;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Cells"
                        "fecha" => "2019"
                        "volumen" => "8"
                        "paginaInicial" => "971"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cancer-associated PIK3CA mutations in overgrowth disorders"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Madsen"
                            1 => "B&#46; Vanhaesebroeck"
                            2 => "R&#46; Semple"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.molmed.2018.08.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Trends Mol Med"
                        "fecha" => "2018"
                        "volumen" => "24"
                        "paginaInicial" => "856"
                        "paginaFinal" => "870"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30197175"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Somatic overgrowth disorders of the PI3K&#47;AKT&#47;mTOR pathway &#38; therapeutic strategies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "K&#46;M&#46; Keppler-Noreuil"
                            1 => "V&#46;E&#46; Parker"
                            2 => "T&#46;N&#46; Darling"
                            3 => "J&#46;A&#46; Martinez-Agosto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.c.31531"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet C Semin Med Genet"
                        "fecha" => "2016"
                        "volumen" => "172"
                        "paginaInicial" => "402"
                        "paginaFinal" => "421"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27860216"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum &#40;PROS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46; Vahidnezhad"
                            1 => "L&#46; Youssefian"
                            2 => "J&#46; Uitto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/exd.12826"
                      "Revista" => array:6 [
                        "tituloSerie" => "Exp Dermatol"
                        "fecha" => "2016"
                        "volumen" => "25"
                        "paginaInicial" => "17"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26268729"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;M&#46; Keppler-Noreuil"
                            1 => "J&#46; Lozier"
                            2 => "N&#46; Oden"
                            3 => "A&#46; Taneja"
                            4 => "J&#46; Burton-Akright"
                            5 => "J&#46;C&#46; Sapp"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.c.31735"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet C Semin Med Genet"
                        "fecha" => "2019"
                        "volumen" => "181"
                        "paginaInicial" => "571"
                        "paginaFinal" => "581"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31490637"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Venous malformation&#58; update on aetiopathogenesis&#44; diagnosis and management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Dompmartin"
                            1 => "M&#46; Vikkula"
                            2 => "L&#46;M&#46; Boon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1258/phleb.2009.009041"
                      "Revista" => array:6 [
                        "tituloSerie" => "Phlebology"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "224"
                        "paginaFinal" => "235"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20870869"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth&#44; vascular malformations&#44; epidermal nevi&#44; and spinal&#47;skeletal abnormalities and Klippel-Tr&#233;naunay syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Reis"
                            1 => "A&#46;I&#46; Alomari"
                            2 => "C&#46;C&#46; Trenor"
                            3 => "D&#46;M&#46; Adams"
                            4 => "S&#46;J&#46; Fishman"
                            5 => "S&#46;A&#46; Spencer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jvsv.2018.01.015"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Vasc Surg Venous Lymphat Disord"
                        "fecha" => "2018"
                        "volumen" => "6"
                        "paginaInicial" => "511"
                        "paginaFinal" => "516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29909856"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109717397632"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Parkes Weber syndrome-diagnostic and management paradigms&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "I&#46; Banzic"
                            1 => "M&#46; Brankovic"
                            2 => "&#381; Maksimovi&#263;"
                            3 => "L&#46; Davidovi&#263;"
                            4 => "M&#46; Markovi&#263;"
                            5 => "Z&#46; Ran&#269;i&#263;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0268355516664212"
                      "Revista" => array:6 [
                        "tituloSerie" => "Phlebology"
                        "fecha" => "2017"
                        "volumen" => "32"
                        "paginaInicial" => "371"
                        "paginaFinal" => "383"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27511883"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Molecular diagnosis of mosaic overgrowth syndromes using a custom-designed next-generation sequencing panel"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Chang"
                            1 => "L&#46; Liu"
                            2 => "E&#46; Fang"
                            3 => "G&#46; Zhang"
                            4 => "T&#46; Chen"
                            5 => "K&#46; Cao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Mol Diagn"
                        "fecha" => "2017"
                        "volumen" => "19"
                        "paginaInicial" => "613"
                        "paginaFinal" => "624"
                        "itemHostRev" => array:3 [
                          "pii" => "S0167527319311040"
                          "estado" => "S300"
                          "issn" => "01675273"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sirolimus is efficacious in treatment for extensive and&#47;or complex slow-flow vascular malformations&#58; a monocentric prospective phase II study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Hammer"
                            1 => "E&#46; Seront"
                            2 => "S&#46; Duez"
                            3 => "S&#46; Dupont"
                            4 => "A&#46; Van Damme"
                            5 => "S&#46; Schmitz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s13023-018-0934-z"
                      "Revista" => array:5 [
                        "tituloSerie" => "Orphanet J Rare Dis"
                        "fecha" => "2018"
                        "volumen" => "13"
                        "paginaInicial" => "191"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30373605"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "&#91;22&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46;E&#46;R&#46; Parker"
                            1 => "K&#46;M&#46; Keppler-Noreuil"
                            2 => "L&#46; Faivre"
                            3 => "M&#46; Luu"
                            4 => "N&#46;L&#46; Oden"
                            5 => "L&#46; De Silva"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/s41436-018-0297-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Genet Med"
                        "fecha" => "2019"
                        "volumen" => "21"
                        "paginaInicial" => "1189"
                        "paginaFinal" => "1198"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30270358"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Targeted therapy in patients with PIK3CA-related overgrowth syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Q&#46; Venot"
                            1 => "T&#46; Blanc"
                            2 => "S&#46;H&#46; Rabia"
                            3 => "L&#46; Berteloot"
                            4 => "S&#46; Ladraa"
                            5 => "J&#46;P&#46; Duong"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/s41586-018-0217-9"
                      "Revista" => array:7 [
                        "tituloSerie" => "Nature"
                        "fecha" => "2018"
                        "volumen" => "558"
                        "paginaInicial" => "540"
                        "paginaFinal" => "546"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29899452"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109703015626"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23870206/0000015700000010/v2_202201010925/S2387020621005702/v2_202201010925/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "44147"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Review"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015700000010/v2_202201010925/S2387020621005702/v2_202201010925/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621005702?idApp=UINPBA00004N"
]
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 March 1 2 3

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos